Regeneron Pharmaceuticals, Inc. ( REGN) - Stock Earnings
REGN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 30, 2026, midnight | — / — | — | — / — | — |
REGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 1.5 billion USD | 3.8 billion USD |
| 2025Q4 | 844.6 million USD | 3.9 billion USD |
| 2026Q1 | 727.2 million USD | 3.6 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
REGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 4.0 billion USD | 13.1 billion USD |
| 2024 | 4.4 billion USD | 14.2 billion USD |
| 2025 | 4.5 billion USD | 14.3 billion USD |
| 2026 Est. | — | — |
REGN
Price: $676.69
Dividend Yield: 0.56%
Forward Dividend Yield: 0.56%
Dividend Per Share: 3.76 USD
Earnings Per Share: 40.99 USD
P/E Ratio: 17.13
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 417600
Ebitda: 597.4 millionMarket Capitalization: 67.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 2